MILGAMMA mono 300 film-coated tablets, 100 pcs

Instructions for use for MILGAMMA mono 300 film-coated tablets, 100 pcs

Indications: Milgamma Mono 300 is used for the treatment or prophylaxis of clinical vitamin B1 deficiencies where these cannot be corrected by diet. It is also used for the treatment of neuropathies and cardiovascular disorders caused by vitamin B1 deficiency. Dosage and directions for use: The recommended dose is one film-coated tablet once daily. The duration of use depends on the symptoms and the success of the treatment, but should be at least three weeks. If necessary, the therapy can be continued or reviewed. Active ingredients / ingredients / ingredients: One film-coated tablet contains 300 mg benfotiamine (fat-soluble vitamin B1 derivative). Other ingredients are microcrystalline cellulose, talc, povidone (K30), highly dispersed silicon dioxide, croscarmellose sodium, higher chain partial glycerides, hypromellose, titanium dioxide, polyethylene glycol and saccharin sodium. Contraindications: Milgamma Mono 300 must not be taken if there is hypersensitivity to any of the ingredients. Side effects: Possible side effects may include hypersensitivity, hives, skin rash, gastrointestinal disorders, nausea and gastrointestinal discomfort. Important information: The medicine should not be taken if there is an allergy to binders or the sweetener saccharin. Interactions with other medicinal products may occur. Storage: The medicinal product should be kept out of the reach of children and should not be used after the expiry date. Commercial forms: The medicinal product is available in packs of 100 film-coated tablets. Manufacturer: Wörwag Pharma GmbH & Co. KG, Böblingen